期刊文献+

JAK2V617F阳性PV与ET实验室检查混淆诊断的患例骨髓细胞形态观察 被引量:1

下载PDF
导出
摘要 目的:真性红细胞增多症(PV)与原发性血小板增多症(ET)临床体征有重叠表现,实验室检查表型间又存在交叉,为明确二者的诊断,减少误诊,将曾经误诊病例的实验室检查数据与骨髓细胞形态学相结合进行分析总结。方法:回顾分析曾误诊的PV、ET患者的外周血结果、骨髓病理活检结果、JAK2V617F基因检测结果、骨髓涂片细胞学检查。结果:JAK2V617F基因阳性,RBC、PLT数明显增高,MCV、HCT偏低,Hb低于WHO规定的PV的诊断标准的病例,依据骨髓形态学诊断为合并缺铁性贫血的PV;IAK2V617F基因阳性,Hb、RBC、WBC外周血计数较高,PLT计数反而较低的病例,依据骨髓形态学诊断为ET。结论:骨髓形态学仍是我们做好PV、ET诊断与鉴别诊断的重要依据。
作者 杨风霞
出处 《医学检验与临床》 2018年第1期62-64,共3页 Medical Laboratory Science and Clinics
  • 相关文献

参考文献1

二级参考文献13

  • 1Tefferi A, Vardiman JW. Classification and diagnosis of myeloprolifer- ative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms [ J ]. Leukemia, 2008, 22 ( 1 ) : 14-22.
  • 2Campbell PJ, Scott LM, Buck G, et al. Definition of subtypes of es- sential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status : a prospective study [ J ]. Lancet, 2005, 366(9501 ) :1945-1953.
  • 3Antonioli E, Guglielmelli P, Pancraszi A. Clinical implications of the JAK2 V617F mutation in essential thrombocytbemia [ J ]. Leuke- mia, 2005,19 (10) : 1847-1849.
  • 4Wolanskyj AP, Lasho TL, Sehwager SM, et al. JAK2 mutation in es- sential thrombocythaemia: clinical associations and long-term prog- nostic relevance [ J ]. Br J Haematol, 2005, 131 (2) :208-213.
  • 5Swerdlow SH, Campo E, Harris NL, et al. (2008) World Health Organization classification of tumours of haematopoietic and lymphoid tissues[ M]. IARC, Lyon, 2008:40-49.
  • 6Spivak JL. Narrative review : thrombocytosis, polycythemia vera, and JAK2 mutations : the phenotypic mimicry of chronic myeloproliferation [J]. Ann Intern Med, 2010, 152(5) :300-306.
  • 7Wadleigh M, Tefferi A. Classification and diagnosis of myeloprolifer- ative neoplasms according to the 2008 World Health Organization cri- teria[J]. Int J Hematol, 2010, 91 (2) :174-179.
  • 8Thiele J, Kvasnicka HM, Vardiman J. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl[J]. Best Pract Res Clin Haematol, 2006,19(3) :413-437.
  • 9Thiele J, Kvasnicka HM. Clinicopathological criteria for differential diagnosis of thrombocythemias in various myeloproliferative disorders [ J]. Semin Thromb Hemost, 2006,32 (3) :219-230.
  • 10Lippert E, Boissinot M, Kralovics R, et al. The JAK2-V617F muta- tion is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera[ J ]. Blood ,2006,108 (6) : 1865-1867.

共引文献4

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部